<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Another application of the nanoemulsification technique with PVP as carrier to produce highly bioavailable SIL NPs with mean size &lt; 200 nm and EE &gt; 97% was reported by Liu et al. [
 <xref rid="B43-molecules-24-02155" ref-type="bibr" class="xref">43</xref>], to test in vitro the antiviral activity against HCV infection in human hepatocytes. Besides, pharmacokinetic studies in rodents revealed an enhanced serum level and superior drug biodistribution to the liver after oral administration of SIL-loaded NPs compared with bare SIL.
</p>
